High hopes for biotech companies / IPOs getting ready to go as startups woo VC investors

High hopes for biotech companies / IPOs getting ready to go as startups woo VC investors Biotechnology leaders are cautiously celebrating the end of a two- year financial slump this autumn as more than a dozen companies line up to go public and the latest class of young startups shows its stuff to potential venture […]


Reducing Multi-Cycle Reviews Is FDA Priority

Reducing Multi-Cycle Reviews Is FDA Priority FDA Commissioner Mark McClellan today described key steps the agency is taking to shorten drug approval times, in his keynote speech at IIR�s Phases conference in Washington, D.C.


Get email updates

Get new actionable insights and updates from BiotechBlog

Do NOT follow this link or you will be banned from the site!